Since September 2019, I have worked as a science writer for the Waisman Center, a research facility on the University of Wisconsin-Madison medical campus that focuses on the study of neurodegenerative and developmental disabilities. Life on the job is an endless exploration of medicine and biology that I often have little experience in, but that provides an excellent example of why I got into science writing: the chance to jump into topics previously unknown to me and share my findings with others. Much of my job so far is trying to understand rare disorders through the people who have them. It’s challenging in all the right ways and the fact that I can use my writing to help people with disabilities is very meaningful to me.
The following are some examples of my work at the Waisman Center:
“Research has shown voluntary running is an activity most commonly associated with the reversal of negative impacts of aging and neurodegeneration, but little is understood about why that is.” In this research paper, the authors explore the importance of physical activity on a single gene that aids in cognitive health. The discovery could potentially lead to treatments for people with neurodegenerative or cognitive diseases.
At a time when biopharmaceutical companies are running at breakneck speeds to produce a vaccine for COVID-19, I consider myself very lucky that I get to be a small part of getting the information out there on at least two companies’ efforts to see that that goal is accomplished.
The ECHO effect
(July 28, 2020)
Access to proper healthcare procedures can be a challenge in states like Wisconsin where so much of the state is so rural. But a new program called ECHO seeks to bridge the gaps that exist by virtually training healthcare professionals to better serve their community. Waisman recently adopted the ECHO model for healthcare training.
Balancing act: what motor function can tell us about autism
(June 15, 2020)
When disease research is combined with machine learning to recognize patterns, really amazing things can happen. In this story, one of our autism investigators wrote a research paper for which she used her Wii balance board to discover some unique motor patterns in individuals with autism.
According to a recent report by the Centers for Disease Control, one in every 54 children in the U.S. is diagnosed with autism. In Wisconsin, the rate is 1 in 60.
The social brain: a beautiful mind
(May 6, 2020)
Sibling studies are important for genetics research because two people who are so similar genetically may provide important insights into why one does or does not inherit a disease. In this piece, a literature review of research on the social brain in young siblings with autism pulls together all of the research on that topic from the previous year and a half into one concise roadmap.
Improved technique illuminates Fragile X protein
(Apr. 9, 2020)
This story is a good example of some of the more complex microbiological studies I’ve had to learn enough about to write intelligibly for a wider audience. Fragile X syndrome is the leading inherited cause of intellectual and developmental disabilities and lack of a single protein in the brain contributes to the more common symptoms. Here, researchers seek to understand more about that protein.
Routine test reveals rare diseases
(Feb. 26, 2020)
Feb. 29 is Rare Disease Day and the communications team wanted to do a story that could raise awareness and still encompass multiple rare diseases. The Wisconsin Newborn Screening Laboratory, which screens for 46 rare diseases, seemed like an excellent fit.
It’s important to note that no scientific work exists in a vacuum. I firmly believe that scientists are providing a public service and their work should be used to enhance community engagement. This story was a delight to work on and is an example of programs that bridge the gap between science and the community.
Whole exome sequencing illuminates genetic condition
(Oct. 18, 2019)
This was a fun one to write. The man pictured had a rare genetic disorder that suddenly left him nearly blind later in life. After years of battling this undiagnosed condition, a trip to a geneticist changed everything. Now able to see, he is one of the most thankful and happy people I’ve ever interviewed.
CMT advocate will not be sidelined
(Sept. 23, 2019)
This is my first story to go live for my job as a science writer for the Waisman Center. It’s about a woman with a rare neurodegenerative disease called CMT and one of our researchers here who is doing a lot of work to understand it’s mechanisms.
*Mason Muerhoff contributed to this story.